Connect with us

Published

on

Fentanyl - A National Security Crisis Demanding Prevention

Disseminated on behalf of ARMR Sciences Inc.

Fentanyl is no longer just another opioid – it has become the single most lethal synthetic drug in the United States. Since 2000, it is estimated that more than 20 million nonfatal overdoses have occurred in the U.S.- surpassing deaths from COVID-19, HIV/AIDS, and even major wars.

Today, fentanyl is the leading cause of death for adults aged 18–45, claiming an estimated 220 lives every single day.

A Silent, Rapid Killer

A minuscule amount – equivalent in size to just a few grains of salt – can be fatal. Fentanyl is fast-acting and often hidden in counterfeit pills or laced into drugs without the user’s knowledge. 

Fentanyl is cheap to manufacture and covertly laced with counterfeit pills and recreational drugs. This stealth factor explains why the vast majority of overdose victims never intended to take fentanyl.

The financial toll is also staggering: the opioid epidemic costs the U.S. economy an estimated $2.7 trillion in 2023 alone, with cumulative losses exceeding $10 trillion over the past two decades.

Why Current Defenses Fall Short

Tools like naloxone (Narcan) have saved lives but remain purely reactive. They only work after an overdose begins and often fail against emerging analogs such as xylazine, nitazenes, or medetomidine, which Narcan cannot reverse. First responders, military personnel, and even families are left without effective long-term defenses.

ARMR’s Preventive Approach

ARMR Sciences is advancing its novel immunotherapy, ARMR-100, designed to train the immune system to block fentanyl before it reaches the brain. In animal studies, ARMR-100 blocked 92% of fentanyl’s entry into the brain and eliminated its addictive behavioral effects. 

Unlike reactive antidotes, this would provide months of protection – functioning like a biochemical shield.

The program is building on seven years of U.S. Department of Defense–funded research and is working to leverage proven vaccine components, such as carrier proteins already approved in licensed products and adjuvants tested in hundreds of clinical trials. 

The Market and ARMR’s Mission

The potential reach is vast: 2.7 million Americans with opioid use disorder, over 2 million first responders and law enforcement officers, more than 18 million military personnel and veterans who experience higher rates of opioid use, chronic pain, and post-traumatic stress disorder, and more than 30 million high-risk young people.

A once or twice annual preventive shot could help transform national defense against fentanyl, making protection scalable across households, schools, hospitals, and security agencies.

The fentanyl crisis is no longer just a health issue – it’s a national security emergency. And we believe prevention, not rescue, may be the only path to saving a generation.

Why Investors Should Pay Attention

ARMR is more than a biotech startup – it is working to tackle America’s most urgent social and health crisis. This is a mission-driven company focused on building a preventive defense platform that could save thousands of lives each year:

  • $30M private raise launched
  • Seven years of DoD-backed research form the foundation
  • Lead candidate ARMR-100 blocked 92% of fentanyl from entering the brain in preclinical studies
  • A targeted exchange listing in the future

By investing in this round, investors have a chance to back a company whose mission is as much about impact as it is about growth potential. 

Invest now to help support ARMR’s efforts to build the nation’s first line of defense against fentanyl and other synthetic threats.

This is a paid advertisement for ARMR’s private offering. Please read the offering circular at InvestARMR.com for additional information on the company and the risk factors related to the offering.


DISCLOSURES & DISCLAIMERS

CLIENT CONTENT: Carboncredits.com is not responsible for any content hosted on ARMR Sciences’ sites; it is ARMR Sciences’ responsibility to ensure compliance with applicable laws.

NOT INVESTMENT ADVICE: Content is for educational, informational, and advertising purposes only and should NOT be construed as securities-related offers or solicitations. All content should be considered promotional and subject to disclosed conflicts of interest. 

Do NOT rely on this as personalized investment advice. Do your own due diligence.

Carboncredits.com strongly recommends you consult a licensed or registered professional before making any investment decision.

REGULATORY STATUS: Neither Carboncredits.com nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor, or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.

CONTENT & COMPENSATION DISCLOSURE: Carboncredits.com has received compensation of thirty thousand dollars from ARMR Sciences for this sponsored content. You should assume we receive compensation as indicated for any purchases through links in this email via affiliate relationships, direct/indirect payments from companies or third parties who may own stock in or have other interests in promoted companies. We may purchase, sell, or hold long or short positions without notice in securities mentioned in this communication.

RESULTS NOT TYPICAL: Past performance and results are unverified and NOT indicative of future results. Results presented are NOT guaranteed as TYPICAL. Market conditions and individual circumstances vary significantly. Actual results will vary widely. Investing in securities is speculative and carries high risk; you may lose some, all, or possibly more than your original investment.

HIGH-RISK: Securities discussed may be highly speculative investments subject to extreme volatility, limited liquidity, and potential total loss. The Securities are suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that such investment could be illiquid for an indefinite period of time. No public market currently exists for the securities, and if a public market develops, it may not continue.


Disclosure: Owners, members, directors, and employees of carboncredits.com have/may have stock or option positions in any of the companies mentioned: None.

Carboncredits.com receives compensation for this publication and has a business relationship with any company whose stock(s) is/are mentioned in this article.

Additional disclosure: This communication serves the sole purpose of adding value to the research process and is for information only. Please do your own due diligence. Every investment in securities mentioned in publications of carboncredits.com involves risks that could lead to a total loss of the invested capital.

Please read our Full RISKS and DISCLOSURE here.

The post Fentanyl – A National Security Crisis Demanding Prevention appeared first on Carbon Credits.

Continue Reading

Carbon Footprint

How to improve Scope 3 data accuracy for CSRD

Published

on

For most businesses, the emissions that matter most sit outside their own walls. Scope 3 emissions, everything generated across your value chain, from the suppliers who make your inputs to the customers who use your products, typically make up the majority of a company’s total carbon footprint. Under the Corporate Sustainability Reporting Directive (CSRD), those value-chain emissions now have to be measured and disclosed with a rigour that spend-based estimates alone struggle to satisfy. This guide sets out how to improve Scope 3 data accuracy for CSRD: the calculation methods open to you, how to move from estimates to verified supplier data, and how to govern that data so it holds up to audit.

Continue Reading

Carbon Footprint

How community stewardship makes carbon credits durable

Published

on

A carbon credit is a commitment that extends well into the future. The tonne of CO₂ compensated for today from a nature-based carbon project must remain out of the atmosphere for good, which means the forest behind the credit has to remain standing long after the transaction is complete. For any buyer, this raises a defining question: What ensures that the forest endures?

Continue Reading

Carbon Footprint

Why Conventional Carbon Offsets Are Losing Boardroom Credibility

Published

on

What replaced the cheap REDD credit on the boardroom slide deck, and why procurement is leading the rewrite.

Three years ago, a corporate slide showing a portfolio of cheap REDD+ credits could carry a board meeting. The number was big, the price was low, and the press release wrote itself. Today, that same slide gets sent back with questions. The questions are uncomfortable, the answers are unclear, and your general counsel is suddenly in the room.

Conventional carbon offsets are not dead. The voluntary carbon market retired 202 million tonnes in 2025, and the Morgan Stanley Institute for Sustainable Investing survey published in January 2026 confirmed that interest from corporate buyers remains substantial. What changed is the credibility threshold. The integrity floor has risen, the disclosure scrutiny has tightened, and the buyer profile has shifted. This article tracks what changed, what sophisticated buyers now ask before signing, and what serious corporates are putting on the board slide instead.

What boards used to buy, and why it stopped working

The 2020 to 2022 model was simple: buy a large tranche of avoidance credits at low single-digit prices, retire them against the company footprint, announce the carbon-neutral claim, and move on. Most of those credits came from REDD+ projects, renewable energy installations in countries where the renewable energy was already economic, or methane projects with thin documentation.

Several things broke that model. Academic research published in 2023, including a widely cited Science paper, found that the majority of REDD+ credits issued under the most common methodologies did not represent additional reductions when tested against rigorous counterfactuals. The Voluntary Carbon Markets Integrity Initiative published its Claims Code of Practice, which sets requirements for what companies can credibly claim from credit use. The European Union finalised its Green Claims Directive, restricting how companies can describe products as climate-neutral. France’s Décret 2022-539 already restricts carbon neutrality advertising. California’s AB 1305 imposes disclosure requirements on any company making net-zero or carbon-neutral claims while doing business in the state.

The collective effect: the cheap credit no longer buys the announcement, and the announcement now carries litigation risk.

The integrity reset: ICVCM, VCMI, and what changed

The Integrity Council for the Voluntary Carbon Market published the Core Carbon Principles in 2023 and began assessing methodologies against them in 2024. The first methodologies received the CCP label later that year. The point of the label is to give corporate buyers a defensible quality screen they can cite in disclosure.

The Voluntary Carbon Markets Integrity Initiative complements this on the demand side. Its Claims Code of Practice defines what a buyer can say (Silver, Gold, or Platinum claims, with associated requirements) based on the quality of credits used and the underlying decarbonisation strategy. Together, CCP and VCMI build a quality stack: CCP on the supply, VCMI on the claim, with the science-based target sitting underneath both.

The reset is not a ban on offsets. It is a ratchet. Credits that meet the new bar continue to clear; credits that do not, do not. The Morgan Stanley survey found that 61% of current buyers like the CCP label concept but that supply of labelled credits remains limited. That supply constraint is now visible in pricing.

What sophisticated buyers ask before they sign

The questions on the procurement scorecard have changed. A 2022 buyer might have asked about price, vintage, and project type. A 2026 buyer asks five different questions before any of those.

  • What does the counterfactual look like, and who validated it.
  • What is the permanence regime, and what is the buffer pool exposure.
  • What is the leakage risk, and how is it mitigated.
  • What rating has the project received from the independent ratings agencies (Sylvera, BeZero, Calyx Global), and what was the rationale.
  • What is the documentation discipline that survives an audit four years from now when the procurement team that signed the contract has moved on.

If the vendor cannot answer those five questions on a first call, the conversation ends. Conversely, if the vendor can answer them with documented specificity, the conversation often expands beyond a single transaction toward a multi-year engagement.

Where this leaves your near-term commitments

You probably have near-term commitments that pre-date the integrity reset. Public targets to be carbon neutral by 2025 or 2030. Product-level claims that ran in last year’s marketing. Disclosed reduction trajectories that assumed continued access to cheap credits.

You have three workable paths. The first is to re-baseline your strategy, replacing the most exposed credits with higher-quality alternatives and adjusting the public language to match what you can defend. The second is to shift the underlying spend from offsetting outside your value chain to investing inside your value chain, where reductions count against Scope 3 directly and the audit trail is cleaner. The third is to keep the strategy and absorb the risk, which is increasingly the most expensive option once you price in litigation, restatement, and reputational exposure.

Most serious buyers are choosing the second path. It moves the carbon spend from a compliance cost to a procurement and resilience investment, and it removes the central failure point of the legacy model: the disconnect between where the emissions occurred and where the reductions sat. Nature-based supply chain investments, structured under the GHG Protocol Land Sector and Removals Standard and aligned to the SBTi FLAG Guidance, are the asset class that fits this brief. They generate inventory-grade reductions, they produce audit-grade documentation, and they survive the new claim restrictions because the carbon math sits inside the value chain that the disclosure already covers.

If you are reassessing a carbon strategy under the new integrity bar, or rebuilding a board narrative that has to survive a more skeptical audience, the carbon and sustainability experts at Carbon Credit Capital can help. The Dual-Value Model gives you a defensible alternative to legacy offset purchases, with the documentation and operational integration that survives the procurement scorecard and the audit. Schedule a consultation.

Continue Reading

Trending

Copyright © 2022 BreakingClimateChange.com